ASKA Pharmaceutical Competitors and Similar CompaniesClear all

ASKA Pharmaceutical's competitors and similar companies include BL&H, Dong-A ST, Phapros and CIS Pharma.

	ASKA Pharmaceutical ASKA Pharmaceutical (あすか製薬株式会社) is a company that develops, manufactures, and sells pharmaceutical products.	BL&H BL&H is a company developing and supplying drugs and medical devices.	Dong-A ST Dong-A ST is a healthcare company that specializes in the development of ethical drugs and medical devices.	Phapros PT Phapros Tbk is engaged in pharmaceutical manufacturing.	CIS Pharma CIS Pharma is a pharmaceutical research and development company specializing in drug delivery.
Founding Date	Founding Date 1920	Founding Date 1999	Founding Date 1932	Founding Date 1954	Founding Date 1952
Type	Type Subsidiary	Type Private	Type Public	Type Public	Type Private
Tags	Tags Healthcare drug development pharma veterinary	Tags Healthcare biotech drug development medical devices medtech veterinary	Tags Healthcare biotech drug development medical devices medtech pharma	Tags Healthcare drug development medical devices medtech pharma	Tags Healthcare biotech drug development life sciences medical devices medtech pharma
Locations	Locations Tokyo, JP HQ Chiba, JP Fujisawa, JP Fukuoka, JP Hiroshima, JP Iwaki, JP Kanazawa, JP see more	Locations HQ	Locations HQ	Locations HQ	Locations Bubendorf, CH HQ
Employees	Employees 635	Employees N/A	Employees 1,533	Employees N/A	Employees 10
Financial
Revenue (est.)	Revenue (est.) ¥52.5b (FY, 2020)	Revenue (est.) N/A	Revenue (est.) ₩808.8b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods ¥24.9b (FY, 2020)	Cost of goods N/A	Cost of goods ₩456.1b (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit ¥27.7b (FY, 2020)	Gross profit N/A	Gross profit ₩356.5b (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income ¥649m (FY, 2020)	Net income N/A	Net income (₩37.6b) (FY, 2025)	Net income N/A	Net income N/A